[1] Ruiz-Ortega M, Rodrigues-Diez R R, Lavoz C, et al. Special issue “diabetic nephropathy: diagnosis, prevention and treatment”[J]. J Clin Med, 2020, 9(3): 813. [2] 中华医学会糖尿病学分会微血管并发症学组. 糖尿病肾病防治专家共识(2014年版)[J]. 中华糖尿病杂志, 2014, 6(11): 792-801. [3] Podgórski P, Konieczny A, Lis Ł, et al. Glomerular podocytes in diabetic renal disease[J]. Adv Clin Exp Med, 2019, 28(12): 1711-1715. [4] Sharma K. Obesity and diabetic kidney disease: role of oxidant stress and redox balance[J]. Antioxid Redox Signal, 2016, 25(4): 208-216. [5] Fakhruddin S, Alanazi W, Jackson K E. Diabetes-induced reactive oxygen species: mechanism of their generation and role in renal injury[J]. J Diabetes Res, 2017, 2017: 8379327. [6] Akbar S, Bellary S, Griffiths H R. Dietary antioxidant interventions in type 2 diabetes patients: a meta-analysis[J]. Bibliographic details, 2011, 11(2): 62-68. [7] 孙雪艳, 赵文景, 刘志强, 等. 保肾通络方对糖尿病肾病Ⅲ~Ⅳ期患者临床疗效及足细胞损伤的影响[J]. 环球中医药, 2020, 13(1): 153-156. [8] 沈存, 王悦芬, 孙雪艳, 等. 保肾通络方治疗2型糖尿病肾脏病气阴两虚兼血瘀证临床观察和足细胞保护机制研究[J]. 四川中医, 2020, 38(7): 142-146. [9] Cui F Q, Wang Y F, Gao Y B, et al. Effects of BSF on podocyte apoptosis via regulating the ROS-mediated PI3K/AKT pathway in DN[J]. J Diabetes Res, 2019, 2019: 9512406. [10] Audzeyenka I, Bieryńska A, Lay A C. Podocyte bioenergetics in the development of diabetic nephropathy: the role of mitochondria[J]. Endocrinology, 2022, 163(1): bqab234. [11] Audzeyenka I, Rachubik P, Typiak M, et al. Hyperglycemia alters mitochondrial respiration efficiency and mitophagy in human podocytes[J]. Exp Cell Res, 2021, 407(1): 112758. [12] Piwkowska A, Rogacka D, Audzeyenka I, et al. High glucose concentration affects the oxidant-antioxidant balance in cultured mouse podocytes[J]. J Cell Biochem, 2011, 112(6): 1661-1672. [13] Lindblom R, Higgins G, Coughlan M, et al. Targeting mitochondria and reactive oxygen species-driven pathogenesis in diabetic nephropathy[J]. Rev Diabet Stud, 2015, 12(1/2): 134-156. [14] Brady N R, Hamacher-Brady A, Westerhoff H V, et al. A wave of reactive oxygen species (ROS)-induced ROS release in a sea of excitable mitochondria[J]. Antioxid Redox Signal, 2006, 8(9/10): 1651-1665. [15] Zhang P N, Zhou M Q, Guo J, et al. Mitochondrial dysfunction and diabetic nephropathy: nontraditional therapeutic opportunities[J]. J Diabetes Res, 2021, 2021: 1010268. [16] Yang M, Li C R, Yang S K, et al. Mitophagy: a novel therapeutic target for treating DN[J]. Curr Med Chem, 2021, 28(14): 2717-2728. [17] Sun A Q, Wei J, Childress C, et al. The E3 ubiquitin ligase NEDD4 is an LC3-interactive protein and regulates autophagy[J]. Autophagy, 2017, 13(3): 522-537. [18] Periyasamy K M, Ranganathan U D, Tripathy S P, et al. Vitamin D - A host directed autophagy mediated therapy for tuberculosis[J]. Mol Immunol, 2020, 127: 238-244. [19] Li W, Du M M, Wang Q Z, et al. FoxO1 promotes mitophagy in the podocytes of diabetic male mice via the PINK1/parkin pathway[J]. Endocrinology, 2017, 158(7): 2155-2167. |